{"title":"Human papillomavirus self-sampling","authors":"Seema Singhal, Saloni Kamboj","doi":"10.4103/jclgtp.jclgtp_15_23","DOIUrl":null,"url":null,"abstract":"Human papillomavirus (HPV)-based cervical screening provides longer protection and thus is more effective in preventing cervical cancer in both low- and good-resource areas. A unique benefit of primary HPV screening is the option of self-sampling that empowers women to take her own samples and then mail these or hand over to health-care workers. Several studies have observed improved participation and better patient satisfaction using self-sampling. There are two modalities utilized for self-sampling: vaginal and urine collection. There is an excellent concordance for HPV detection between self- and physician-collected samples. Several HPV assays are available in market. However, there is a need to standardize the collection, storage, transport, and testing conditions. VALidation of HUman papillomavirus assays and collection DEvices for HPV testing on self-samples and urine samples protocols were formulated after intense research for the standardization of conditions for HPV testing in both vaginal and urine samples. There are several devices available for vaginal self-collection and Colli-Pee device is available for urine collection. The analytical and clinical performance of HPV assays to detect high-risk HPV on self-collected samples is comparable with the physician-collected samples and also with cytology. Well-designed studies are needed to evaluate the feasibility, efficacy, and cost-effectiveness of self-sampling in contextual settings before these can be recommended for the programmatic implementation.","PeriodicalId":476164,"journal":{"name":"Journal of Colposcopy and Lower Genital Tract Pathology","volume":"112 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Colposcopy and Lower Genital Tract Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jclgtp.jclgtp_15_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Human papillomavirus (HPV)-based cervical screening provides longer protection and thus is more effective in preventing cervical cancer in both low- and good-resource areas. A unique benefit of primary HPV screening is the option of self-sampling that empowers women to take her own samples and then mail these or hand over to health-care workers. Several studies have observed improved participation and better patient satisfaction using self-sampling. There are two modalities utilized for self-sampling: vaginal and urine collection. There is an excellent concordance for HPV detection between self- and physician-collected samples. Several HPV assays are available in market. However, there is a need to standardize the collection, storage, transport, and testing conditions. VALidation of HUman papillomavirus assays and collection DEvices for HPV testing on self-samples and urine samples protocols were formulated after intense research for the standardization of conditions for HPV testing in both vaginal and urine samples. There are several devices available for vaginal self-collection and Colli-Pee device is available for urine collection. The analytical and clinical performance of HPV assays to detect high-risk HPV on self-collected samples is comparable with the physician-collected samples and also with cytology. Well-designed studies are needed to evaluate the feasibility, efficacy, and cost-effectiveness of self-sampling in contextual settings before these can be recommended for the programmatic implementation.